Matribhumi Samachar English
Vancouver, British Columbia–(Newsfile Corp. – October 10, 2025) – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the “Company” or “PreveCeutical”), is pleased to announce that all resolutions presented at the Company’s annual general and special meeting (the “Meeting“) held on Friday, October 10, 2025, including the following: the election of …
Read More »PreveCeutical Announces Mailing and Filing of Annual General and Special Meeting Materials in Connection with a Proposed Arrangement with BioGene Therapeutics
Vancouver, British Columbia–(Newsfile Corp. – September 19, 2025) – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the “Company” or “PreveCeutical”), announces that further to its News Release of September 4, 2025, it has filed with the applicable Canadian securities regulatory authorities the management information circular dated September 9, 2025 and …
Read More »PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement
Vancouver, British Columbia–(Newsfile Corp. – September 5, 2025) – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the “Company” or “PreveCeutical”), is pleased to announce that, further to its news release dated August 5, 2025, it has closed an initial tranche (the “Initial Tranche“) of its previously announced $1,000,000 non-brokered private …
Read More »PreveCeutical Announces Rescheduled Date for Annual General and Special Meeting and Director Resignation
Vancouver, British Columbia–(Newsfile Corp. – August 28, 2025) – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) (the “Company” or “PreveCeutical”) announces that, further to its News Release of June 25, 2025, July 8, 2025 and August 5, 2025, it has rescheduled its annual general and special meeting (the “Meeting“) from …
Read More »